These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3032326)

  • 1. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.
    Waller PC; McInnes GT
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):769. PubMed ID: 3032326
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin converting enzyme inhibitor and angiotensin II analogue on hypertension. Study of hypertension with two different blockers of the renin-angiotensin-aldosterone system.
    Kodama K; Morotomi Y; Kida O; Higa T; Someya N; Kondo K; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):353-61. PubMed ID: 2991636
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
    Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
    J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hypertension with angiotensin converting enzyme inhibitors.
    Johnston CI; McGrath BP; Matthews PG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of essential hypertension.
    Stott DJ; Ball SG
    Br J Hosp Med; 1986 Oct; 36(4):261-2, 264-5, 268-9. PubMed ID: 2876740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
    Bianchi MD; Fernandes M
    N Engl J Med; 1980 Jan; 302(3):179. PubMed ID: 6243169
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical use of angiotensin converting enzyme inhibitors].
    Fyhrquist F
    Duodecim; 1986; 102(22):1709-16. PubMed ID: 3026771
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypertension treatment 1985: significance of calcium antagonists and angiotensin-converting enzyme inhibitors].
    Weidmann P
    Ther Umsch; 1985 Aug; 42(8):528-39. PubMed ID: 2996166
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.
    Case DB; Wallace JM; Keim HJ; Weber MA; Sealey JE; Laragh JH
    N Engl J Med; 1977 Mar; 296(12):641-6. PubMed ID: 190537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of the renin-angiotensin system in treating arterial hypertension].
    Fagard R; Leuven KU; Staessen J; Amery A
    Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug information. New principle in the treatment of elevated blood pressure].
    Dahlerup J
    Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some advances in angiotensin converting enzyme inhibitors].
    Jia L
    Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the clinical utility of converting enzyme inhibitors in cardiovascular disease. November 10, 1985, Washington, D.C.
    Am J Med; 1986 Oct; 81(4C):1-50. PubMed ID: 3022579
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure.
    Dickstein K
    Int J Cardiol; 1987 Apr; 15(1):1-5. PubMed ID: 3032812
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in therapeutics: converting enzyme inhibition and the kidney.
    Hollenberg NK
    Am J Med; 1985 Sep; 79(3C):1-2. PubMed ID: 2996340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.